Streetbeat News

Regulatory

SNPX

Synaptogenix has received FDA authorization for its Investigational New Drug (IND) application to conduct a trial of Bryostatin-1 in treating Multiple Sclerosis.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:13 pm

KDLY

KindlyMD, Inc. (NASDAQ: KDLY) has successfully registered on SAM.gov and submitted its first grant application for the USDA Rural Utilities Service Distance Learning and Telemedicine Grant Program. This registration opens up numerous federal funding opportunities for the company.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 1:11 pm

STAF

Trading halt status for STAF was updated at 8:55:00 AM ET. The halt was due to pending news and the resumption times were provided.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:55 pm

OMIC

Trading halt status for OMIC was updated at 8:55:00 AM ET. The halt was due to pending news, and trading is expected to resume shortly.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:55 pm

SILO

Silo Pharma has awarded a contract to its Contract Research Organization partner, AmplifyBio, for an IND-enabling large animal GLP study of SPC-15, a novel intranasal therapeutic for PTSD. This study advances SPC-15 towards its first-in-human trial.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:52 pm

NUWE

Nuwellis, Inc. (NUWE) has announced a 1-for-35 reverse stock split, which will consolidate every 35 shares of its common stock into one share. This move is aimed at regaining compliance with the Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:46 pm

BHP

BHP Group Ltd (NYSE:BHP) anticipates an increase in carbon emissions for 2024 due to organic growth and lower metal content in extracted ore. Despite this, BHP remains committed to reducing its operational greenhouse gas emissions by 30% from 2020 levels by 2030. The company plans to increase the use of solar power and transition to full-battery electric trucks. BHP also aims to collaborate with steel producers to reduce emissions intensity by 30% by 2030 and is considering ammonia-fueled ships and methane drainage to cut emissions in shipping and coal mining.

Portfolio Pulse from Stjepan Kalinic

June 26, 2024 | 12:40 pm

CBUS

Cibus has expanded its intellectual property coverage by securing additional patents for 10 plant trait and editing families. This strengthens its portfolio in areas such as pod shatter reduction, herbicide tolerances, high fiber wheat, and improved quality alfalfa. The patents cover regions including Europe, Asia, Latin America, Canada, and the U.S.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:40 pm

JAGX

Jaguar Health has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:35 pm

GILD

Gilead Sciences Canada announced that its Phase 3 PURPOSE 1 trial for Lenacapavir showed 100% efficacy in preventing HIV in cisgender women. An independent Data Monitoring Committee recommended stopping the blinded phase and offering open-label Lenacapavir to all participants.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:34 pm